Related Experiment Video

Updated: May 27, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

TGF-β and its coreceptors in cancerogenesis: an overview

Nataša Todorović-Raković1, Jelena Milovanović, Dragica Nikolić-Vukosavljević

  • 1Department of Experimental Oncology, Institute for Oncology & Radiology of Serbia, Pasterova 14, Belgrade, Serbia.

Biomarkers in Medicine
|November 23, 2011
PubMed

Insights

Coreceptors like endoglin and β-glycan are crucial for transforming growth factor-beta (TGF-β) pathway signaling. Understanding their roles is key to exploring TGF-β in cancer therapy.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • The transforming growth factor-beta (TGF-β) pathway is critical in cellular processes.
  • Key signaling involves TGF-β receptors I and II, alongside auxiliary receptors (coreceptors).
  • Endoglin and β-glycan are significant coreceptors in TGF-β signaling.

Purpose of the Study:

  • To elucidate the complex roles of endoglin and β-glycan in TGF-β pathway regulation.
  • To understand how these coreceptors influence ligand availability and receptor interactions.
  • To highlight the importance of coreceptor function in cancer biology and potential therapeutics.

Main Methods:

  • Review of recent studies on TGF-β coreceptors.
  • Analysis of molecular mechanisms governing coreceptor-ligand-receptor interactions.
  • Exploration of context-dependent signaling variations.

Main Results:

  • Endoglin and β-glycan significantly modulate TGF-β ligand availability to main receptors.
  • These coreceptors influence receptor binding affinity and downstream signaling outcomes.
  • Their function is variable and highly dependent on cellular context.

Conclusions:

  • Endoglin and β-glycan are essential regulators of TGF-β pathway complexity.
  • A deeper understanding of their mechanisms is vital for cancer research.
  • Targeting these coreceptors offers potential therapeutic strategies for manipulating the TGF-β system in cancer.

More Related Videos

Spheroid Assay to Measure TGF-β-induced Invasion09:18

Spheroid Assay to Measure TGF-β-induced Invasion

Published on: November 16, 2011

A Mouse Model to Investigate the Role of Cancer-Associated Fibroblasts in Tumor Growth06:35

A Mouse Model to Investigate the Role of Cancer-Associated Fibroblasts in Tumor Growth

Published on: December 22, 2020

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...